Chemed Corporation (CHE)
NYSE: CHE · Real-Time Price · USD
570.96
+7.68 (1.36%)
Nov 22, 2024, 4:00 PM EST - Market closed
Chemed Revenue
Chemed had revenue of $606.18M in the quarter ending September 30, 2024, with 7.38% growth. This brings the company's revenue in the last twelve months to $2.38B, up 6.83% year-over-year. In the year 2023, Chemed had annual revenue of $2.26B with 6.06% growth.
Revenue (ttm)
$2.38B
Revenue Growth
+6.83%
P/S Ratio
3.62
Revenue / Employee
$157,567
Employees
15,087
Market Cap
8.52B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.26B | 129.45M | 6.06% |
Dec 31, 2022 | 2.13B | -4.30M | -0.20% |
Dec 31, 2021 | 2.14B | 59.68M | 2.87% |
Dec 31, 2020 | 2.08B | 141.03M | 7.27% |
Dec 31, 2019 | 1.94B | 155.91M | 8.75% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
The Ensign Group | 4.11B |
Jazz Pharmaceuticals | 3.99B |
Bruker | 3.24B |
Teleflex | 3.03B |
Tempus AI | 640.44M |
Repligen | 633.51M |
Doximity | 516.85M |
Glaukos | 360.35M |
CHE News
- 7 days ago - Chemtrade Logistics Income Fund (CGIFF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 50 Cents - Business Wire
- 17 days ago - Chemed Corporation to Present at the UBS 2024 Global Healthcare Conference - Business Wire
- 23 days ago - Chemed Corporation (CHE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 24 days ago - Chemed Reports Third-Quarter 2024 Results - Business Wire
- 2 months ago - LEO Pharma Unveils Most Extensive EADV Program To Date with 5 Late Breaking Abstracts and 23 Posters Sharing Clinical and Real-World Data - Business Wire
- 2 months ago - Chemed To Report Third-Quarter 2024 Earnings October 29, Related Conference Call To Be Held On October 30 - Business Wire
- 3 months ago - Chemed Remains A Buy On Long-Term Economics - Seeking Alpha